These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20406312)

  • 1. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.
    Duru OK; Mangione CM; Hsu J; Steers WN; Quiter E; Turk N; Ettner SL; Schmittdiel JA; Tseng CW
    J Am Geriatr Soc; 2010 May; 58(5):822-8. PubMed ID: 20406312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
    Dusetzina SB; Sarpatwari A; Carrier MA; Hansen RA; Keating NL; Huskamp HA
    JAMA Intern Med; 2021 Dec; 181(12):1605-1611. PubMed ID: 34661600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
    Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
    J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.
    Sacks NC; Burgess JF; Cabral HJ; Pizer SD; McDonnell ME
    J Gen Intern Med; 2013 Jul; 28(7):876-85. PubMed ID: 23404199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Medicare Part D coverage gap on medication adherence.
    Zhang Y; Baik SH; Lave JR
    Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study.
    Schmittdiel JA; Steers N; Duru OK; Ettner SL; Brown AF; Fung V; Hsu J; Quiter E; Tseng CW; Mangione CM
    BMC Health Serv Res; 2010 Jun; 10():164. PubMed ID: 20546616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
    Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
    J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.
    Williams J; Steers WN; Ettner SL; Mangione CM; Duru OK
    Med Care; 2013 Feb; 51(2):193-8. PubMed ID: 23032359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
    Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
    Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.
    Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF; Fu J; Simien L; Tseng CW
    J Gen Intern Med; 2014 Jan; 29(1):230-6. PubMed ID: 23975059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
    Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
    Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder.
    Smith KJ; Baik SH; Reynolds CF; Rollman BL; Zhang Y
    Am J Manag Care; 2013 Feb; 19(2):e55-63. PubMed ID: 23448115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.